Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions**Nothing in this study implies endorsement of the products of Medtronic, Inc.
2004 ◽
Vol 94
(11)
◽
pp. 1445-1449
◽
1998 ◽
Vol 31
(2)
◽
pp. 121A
1998 ◽
Vol 31
◽
pp. 121
1998 ◽
Vol 9
(6)
◽
pp. 588-595
◽
2003 ◽
Vol 107
(24)
◽
pp. 3028-3033
◽
2015 ◽
Vol 1
(4)
◽
pp. 257-259
◽